Compare ORRF & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORRF | VALN |
|---|---|---|
| Founded | 1919 | 2012 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 737.4M | 820.0M |
| IPO Year | N/A | 2021 |
| Metric | ORRF | VALN |
|---|---|---|
| Price | $34.91 | $8.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $42.00 | $15.75 |
| AVG Volume (30 Days) | ★ 324.6K | 24.2K |
| Earning Date | 01-30-2026 | 11-20-2025 |
| Dividend Yield | ★ 3.09% | N/A |
| EPS Growth | ★ 198.98 | N/A |
| EPS | ★ 3.78 | N/A |
| Revenue | ★ $247,296,000.00 | $211,089,992.00 |
| Revenue This Year | $26.82 | $3.64 |
| Revenue Next Year | $2.18 | $12.23 |
| P/E Ratio | $9.23 | ★ N/A |
| Revenue Growth | ★ 66.90 | 13.48 |
| 52 Week Low | $25.57 | $4.20 |
| 52 Week High | $38.38 | $12.25 |
| Indicator | ORRF | VALN |
|---|---|---|
| Relative Strength Index (RSI) | 35.58 | 54.83 |
| Support Level | $35.92 | $8.07 |
| Resistance Level | $37.99 | $8.97 |
| Average True Range (ATR) | 0.65 | 0.34 |
| MACD | -0.35 | 0.08 |
| Stochastic Oscillator | 0.72 | 97.92 |
Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time, and savings deposits and granting loans. The company is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services that include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based account maintenance and overdraft services, It also earns wealth management and investment brokerage fees from its contracts with trusts. The company operates in a segment, namely Community Banking.
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.